Novotech, Quintiles And Pharma Firms Debate Pros And Cons Of Outsourcing Clinical Trials Globally

Published: Apr 04, 2005

DALLAS--(BUSINESS WIRE)--April 4, 2005--Novotech, Australia's leading contract research organization (CRO), today announced that Novotech CEO Alek Safarian will debate the pros and cons of outsourcing globally at the 14th Annual Partnership with CROs and other Outsourcing Providers (April 4-6 Dallas). Other panelists include executives from pharma firms, and Quintiles Transnational.

Back to news